Insulet (PODD) Competitors

Becton, Dickinson and Company (NYSE:BDX) and Insulet (NASDAQ:PODD) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, community ranking, institutional ownership and media sentiment.

Do institutionals and insiders hold more shares of BDX or PODD?

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.3% of Becton, Dickinson and Company shares are owned by company insiders. Comparatively, 0.5% of Insulet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts rate BDX or PODD?

Becton, Dickinson and Company presently has a consensus price target of $283.50, indicating a potential upside of 24.52%. Insulet has a consensus price target of $267.44, indicating a potential upside of 0.33%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, equities research analysts clearly believe Becton, Dickinson and Company is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Insulet	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81

Which has higher earnings & valuation, BDX or PODD?

Becton, Dickinson and Company has higher revenue and earnings than Insulet. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$20.18B	3.26	$1.71B	$5.94	38.33
Insulet	$1.98B	9.43	$206.30M	$5.84	45.65

Does the MarketBeat Community believe in BDX or PODD?

Insulet received 130 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 66.27% of users gave Insulet an outperform vote while only 62.32% of users gave Becton, Dickinson and Company an outperform vote.

Company	Underperform	Outperform
Becton, Dickinson and Company	Outperform Votes 597 62.32%	Underperform Votes 361 37.68%
Insulet	Outperform Votes 727 66.27%	Underperform Votes 370 33.73%

Which has more risk & volatility, BDX or PODD?

Becton, Dickinson and Company has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Insulet has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

Does the media prefer BDX or PODD?

In the previous week, Becton, Dickinson and Company had 20 more articles in the media than Insulet. MarketBeat recorded 28 mentions for Becton, Dickinson and Company and 8 mentions for Insulet. Insulet's average media sentiment score of 1.09 beat Becton, Dickinson and Company's score of 0.50 indicating that Insulet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	9 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Positive
Insulet	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is BDX or PODD more profitable?

Insulet has a net margin of 21.22% compared to Becton, Dickinson and Company's net margin of 8.55%. Insulet's return on equity of 27.98% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	8.55%	14.89%	6.98%
Insulet	21.22%	27.98%	9.16%

Summary

Insulet beats Becton, Dickinson and Company on 11 of the 18 factors compared between the two stocks.